KRTX

A Busy Week of Insider Buying 8-20-21 and $CASI, a 10 bagger in 2 Years

by

For trade, details click on this link to the trades.  If there’s one name on this list that I think offers extraordinary opportunity, it would be Casi Pharmaceuticals. It’s been a painful holding for us but take a look at our analysis. CASI looks like a 10 bagger in two years or less. There is something very different now about this stock market than the one we started the year with.  There has been a steady collapse in speculative fervor across the entire market.  You only have to look at the embodiment of it, notable fund manager superstar, Kathie Woods … Read more

Notable Insider Buying Week 11-29-19

by

  Shares of Karuna Therapeutics Inc. KRTX, more than tripled (up 254%) November 19th in active trading to an intraday high of $123.99 after a phase 2 trial of its schizophrenia treatment met its primary endpoint.  Karuna and its underwriters, led by Goldman Sachs et al, wasted no time rushing out a sport secondary at $96 raising $250 million. At Friday’s close of $71.88, people lost serious money in this secondary, including biotech VC and hedge fund Sofinnova Venture Partners which upped their position by$15 million.  No tears shed as they are early investors, buying $15 million on the IPO at … Read more